سعر ديرماسول 0.05% مرهم 20 جم 2022

Egyptian clobetasol propionate 0.05% ointment 20 gm, by T3A Pharma.

• Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Super-high potency: treatment beyond 2 consecutive weeks not recommended; total dosage should not exceed 50 g/week (US clobetasol propionate 0.05% cream labeling).Population: See labelDailyMed (NLM)

• Most frequent: burning and stinging (~1%). Less frequent: itching, skin atrophy, cracking/fissuring. With topical corticosteroids: dryness, acneiform eruptions, hypopigmentation, striae, secondary infection; Cushing syndrome reported with prolonged use.International label, equivalent formulation · DailyMed (NLM)

• Contraindicated in patients with a history of hypersensitivity to any component of the preparation.International label, equivalent formulation · DailyMed (NLM)

• Do not use for rosacea or perioral dermatitis; should not be used on the face, groin, or axillae. Risk of HPA-axis suppression, Cushing syndrome, hyperglycemia. Not for ophthalmic, oral, or intravaginal use. Avoid occlusion unless directed.International label, equivalent formulation · DailyMed (NLM)

• Pregnancy Category C (historical US labeling): corticosteroids are teratogenic in animals; use during pregnancy only if potential benefit justifies potential risk to the fetus. Caution in nursing mothers.International label, equivalent formulation · DailyMed (NLM)

• Clobetasol propionate: Induces lipocortins that inhibit phospholipase A2, reducing prostaglandin/leukotriene mediators of inflammation.